Hainaut P - Search Results

1

Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.

Fernández-Cuesta L, Oakman C, Falagan-Lotsch P, Smoth KS, Quinaux E, Buyse M, Dolci MS, Azambuja ED, Hainaut P, Dell'orto P, Larsimont D, Francis PA, Crown J, Piccart-Gebhart M, Viale G, Leo AD, Olivier M. Fernández-Cuesta L, et al. Among authors: hainaut p. Breast Cancer Res. 2012 May 2;14(3):R70. doi: 10.1186/bcr3179. Breast Cancer Res. 2012. PMID: 22551440 Free PMC article. Clinical Trial.

2

Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines.

Fernández-Cuesta L, Anaganti S, Hainaut P, Olivier M. Fernández-Cuesta L, et al. Among authors: hainaut p. Breast Cancer Res Treat. 2011 Jan;125(1):35-42. doi: 10.1007/s10549-010-0819-x. Epub 2010 Mar 11. Breast Cancer Res Treat. 2011. PMID: 20221692

3

p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines.

Fernandez-Cuesta L, Anaganti S, Hainaut P, Olivier M. Fernandez-Cuesta L, et al. Among authors: hainaut p. Int J Cancer. 2011 Apr 15;128(8):1813-21. doi: 10.1002/ijc.25512. Int J Cancer. 2011. PMID: 20549698

4

TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis.

Olivier M, Hainaut P. Olivier M, et al. Among authors: hainaut p. Semin Cancer Biol. 2001 Oct;11(5):353-60. doi: 10.1006/scbi.2001.0390. Semin Cancer Biol. 2001. PMID: 11562177 Review.

5

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA. Olivier M, et al. Among authors: hainaut p. Cancer Res. 2003 Oct 15;63(20):6643-50. Cancer Res. 2003. PMID: 14583457

6

The tumor suppressor gene TP53: implications for cancer management and therapy.

Seemann S, Maurici D, Olivier M, Caron de Fromentel C, Hainaut P. Seemann S, et al. Among authors: hainaut p. Crit Rev Clin Lab Sci. 2004;41(5-6):551-83. doi: 10.1080/10408360490504952. Crit Rev Clin Lab Sci. 2004. PMID: 15603511 Review.

7

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

Olivier M, Langerød A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bièche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Børresen-Dale AL. Olivier M, et al. Among authors: hainaut p. Clin Cancer Res. 2006 Feb 15;12(4):1157-67. doi: 10.1158/1078-0432.CCR-05-1029. Clin Cancer Res. 2006. PMID: 16489069

8

Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.

Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P. Palmero EI, et al. Among authors: hainaut p. Curr Opin Oncol. 2010 Jan;22(1):64-9. doi: 10.1097/CCO.0b013e328333bf00. Curr Opin Oncol. 2010. PMID: 19952748 Review.

9

TP53 mutations in human cancers: origins, consequences, and clinical use.

Olivier M, Hollstein M, Hainaut P. Olivier M, et al. Among authors: hainaut p. Cold Spring Harb Perspect Biol. 2010 Jan;2(1):a001008. doi: 10.1101/cshperspect.a001008. Cold Spring Harb Perspect Biol. 2010. PMID: 20182602 Free PMC article. Review.

10

p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines.

Anaganti S, Fernández-Cuesta L, Langerød A, Hainaut P, Olivier M. Anaganti S, et al. Among authors: hainaut p. Cancer Lett. 2011 Jan 28;300(2):215-24. doi: 10.1016/j.canlet.2010.10.008. Epub 2010 Nov 10. Cancer Lett. 2011. PMID: 21071137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

474 results

Search Page